SYRACUSE, N.Y., Sept. 23, 2020 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of epigenetic diagnostic tools, announced today that it has received an Emergency Use Authorization (EUA) from the ...
Quadrant Biosciences said late Wednesday it received an emergency approval from the Food and Drug Administration for a saliva-based COVID-19 test. The privately held Syracuse, N.Y.-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results